Immunogenetic mechanisms of recurrent pathological vaginal discharge in women of reproductive age
Uruymagova A.T., Mezhevitinova E.A., Donnikov A.E.
Objective: To identify immunogenetic factors that predispose women of reproductive age to recurrent pathological vaginal discharge.
Materials and methods: This study enrolled 173 women of reproductive age: 59 with episodic pathological vaginal discharge, 74 with recurrent pathological discharge, and 40 healthy women (control group). Genotyping of single nucleotide polymorphisms (SNPs) in immune-regulatory genes (CD14, CTLA4, IFN-γ, IGF-2, IL-10, IL-12β, IL-18, IL-1α, IL-1β, IL-1R, IL-2, IL-4, IL-4R, IL-6, IL-6R, IL-8, TGFβ1, TNF, and MBL2) and genes associated with the neuroendocrine stress response (CRH, CRHR1, and CRHR22) was performed using PCR-based SNP typing. The expression of cytokine (IL-1β, IL-10, IL-18, and TNF-α) and innate immunity receptor (TLR4) mRNAs in vaginal samples was measured by real-time RT-PCR. Statistical analysis included comparisons of allele/genotype frequencies, risk ratio (RR) calculations with 95% confidence intervals, χ² test, Mann–Whitney test, and multivariate logistic regression (significance at p<0.05).
Results: Recurrent pathological vaginal discharge was associated with alterations in local immune response. In the group with recurrent inflammatory discharge, there was significantly increased expression of the anti-inflammatory cytokine IL-10 and decreased IL-18 expression compared to episodic cases, indicating an imbalance in immune regulation. Patients with non-inflammatory recurrences exhibit a different immune profile, characterized by elevated levels of the pro-inflammatory cytokines TNF-α and IL-10. Statistically significant associations were identified between genetic variants and disease recurrence. The GG genotype of the IL-10 -1082 G>A polymorphism increased the risk of recurrent pathological discharge of both inflammatory and non-inflammatory origins, whereas the GG genotypes of the TNF-α -238 G>A polymorphism and CRHR1 (rs17689966) polymorphism significantly increased the likelihood of recurrence in cases of non-inflammatory discharge.
Conclusion: Recurrence of pathological vaginal discharge is driven by a combination of local immune imbalance and genetic predisposition. Polymorphisms in immune-related genes (IL-10, TNF, and CRHR1) may serve as molecular genetic markers of recurrence risk, paving the way for personalized prevention and treatment strategies.
Authors' contributions: Uruymagova A.T., Mezhevitinova E.A., Donnikov A.E. – conception and design of the study, obtaining data for analysis, review of relevant literature, analysis of the obtained data, drafting of the manuscript.
Conflicts of interest: The authors have no conflicts of interest to declare.
Funding: There was no funding for this study.
Ethical Approval: The study was reviewed and approved by the Research Ethics Committee of the V.I. Kulakov NMRC for OG&P, Ministry of Health of Russia.
Patient Consent for Publication: All patients provided informed consent for the publication of their data.
Authors' Data Sharing Statement: The data supporting the findings of this study are available upon request from the corresponding author after approval from the principal investigator.
For citation: Uruymagova A.T., Mezhevitinova E.A., Donnikov A.E. Immunogenetic mechanisms of
recurrent pathological vaginal discharge in women of reproductive age.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2025; (7): 103-111 (in Russian)
https://dx.doi.org/10.18565/aig.2025.138
Keywords
References
- Coudray M.S., Madhivanan P. Bacterial vaginosis – a brief synopsis of the literature. Eur. J. Obstet. Gynecol. Reprod. Biol. 2019; 245: 143-8. https://dx.doi.org/10.1016/j.ejogrb.2019.12.035
- Donders G.G.G., Bellen G., Grinceviciene S., Ruban K., Vieira-Baptista P. Aerobic vaginitis: no longer a stranger. Res. Microbiol. 2017; 168(9-10): 845-58. https://dx.doi.org/10.1016/j.resmic.2017.04.004
- Sherrard J., Wilson J., Donders G., Mendling W., Jensen J.S. European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge. Int. J. STD AIDS. 2018; 29(13): 1258-72. https://dx.doi.org/10.1177/0956462418785451
- Geng N., Wu W., Fan A., Han C., Wang C., Wang Y. et al. Analysis of the risk factors for aerobic vaginitis: a case-control study. Gynecol. Obstet. Invest. 2015. https://dx.doi.org/10.1159/000431286
- Muzny C.A., Sunesara I.R., Austin E.L., Mena L.A., Schwebke J.R. Bacterial vaginosis among African American women who have sex with women. Sex. Transm. Dis. 2013; 40(9): 751-5. https://dx.doi.org/10.1097/OLQ.0000000000000004
- Hunt S., Vollenhoven B. Pelvic inflammatory disease and infertility. Aust. J. Gen. Pract. 2023; 52(4): 229-33. https://dx.doi.org/10.31128/AJGP-09-22-6576
- Gillet E., Meys J.F.A., Verstraelen H., Verhelst R., Sutter P. de, Temmerman M. et al. Association between bacterial vaginosis and cervical intraepithelial neoplasia: systematic review and meta-analysis. PLOS One. 2012; 7(10): e45201. https://dx.doi.org/10.1371/journal.pone.0045201
- Ji L., Peng C., Bao X. Effect of vaginal flora on clinical outcome of frozen embryo transfer. Front. Cell. Infect. Microbiol. 2022; 12: 987292. https://dx.doi.org/10.3389/fcimb.2022.987292
- Nguyen A.T.C., Nguyen N.T.L., Hoang T.T.A., Nguyen T.T., Tran T.T.Q., Tran D.N.T. et al. Aerobic vaginitis in the third trimester and its impact on pregnancy outcomes. BMC Pregnancy Childbirth. 2022; 22(1): 432. https://dx.doi.org/10.1186/s12884-022-04761-5
- Dingens A.S., Fairfortune T.S., Reed S., Mitchell C. Bacterial vaginosis and adverse outcomes among full-term infants: a cohort study. BMC Pregnancy Childbirth. 2016; 16(1): 278. https://dx.doi.org/10.1186/s12884-016-1073-y
- Workowski K.A., Bolan G.A.; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm. Rep. 2015; 64(RR-03): 1-137.
- Donders G.G., Vereecken A., Bosmans E., Dekeersmaecker A., Salembier G., Spitz B. Definition of a type of abnormal vaginal flora that is distinct from bacterial vaginosis: aerobic vaginitis. BJOG. 2002; 109(1): 34-43. https://dx.doi.org/10.1111/j.1471-0528.2002.00432.x
- Taylor B.D., Darville T., Ferrell R.E., Ness R.B., Kelsey S.F., Haggerty C.L. Cross-sectional analysis of Toll-like receptor variants and bacterial vaginosis in African-American women with pelvic inflammatory disease. Sex. Transm. Infect. 2014; 90(6): 436-41. https://dx.doi.org/10.1136/sextrans-2014-051524
- Mackelprang R.D., Scoville C.W., Cohen C.R., Ondondo R.O., Bigham A.W., Celum C., et al. Toll-like receptor gene variants and bacterial vaginosis among HIV-1 infected and uninfected African women. Genes Immun. 2015; 16(5): 362. https://dx.doi.org/10.1038/gene.2015.13
- Murphy K., Shi Q., Hoover D.R., Adimora A.A., Alcaide M.L., Brockmann S. et al. Genetic predictors for bacterial vaginosis in women living with and at risk for HIV in the United States. Am. J. Reprod. Immunol. 2024; 91(1): e13845. https://dx.doi.org/10.1111/aji.13845
- Kalia N., Singh J., Rauniyar A.K., Kaur M. A meta-analysis of mannose-binding lectin gene polymorphisms with the risk of recurrent vulvovaginal infections. Sci. Rep. 2020; 10(1): 6079. https://dx.doi.org/10.1038/s41598-020-63261-8
- De Seta F., Maso G., Piccoli M., Bianchini E., Crovella S., De Santo D. et al. The role of mannose-binding lectin gene polymorphisms in women with recurrent bacterial vaginosis. Am. J. Obstet. Gynecol. 2007; 197(6): 613.e1-e3. https://dx.doi.org/10.1016/j.ajog.2007.04.009
- Kalia N., Singh J., Kaur M. Immunopathology of recurrent vulvovaginal infections: new aspects and research directions. Front. Immunol. 2019; 10: 2034. https://dx.doi.org/10.3389/fimmu.2019.02034
- Usyk M., Schlecht N.F., Pickering S., Williams L., Sollecito C.C., Gradissimo A. et al. molBV reveals immune landscape of bacterial vaginosis and predicts human papillomavirus infection natural history. Nat. Commun. 2022; 13(1): 233. https://dx.doi.org/10.1038/s41467-021-27628-3
- Ge G., Yang Z., Li D. Distinct host immune responses in recurrent vulvovaginal candidiasis and vulvovaginal candidiasis. Front. Immunol. 2022; 13: 959740. https://dx.doi.org/10.3389/fimmu.2022.959740
- Atashili J., Poole C., Ndumbe P.M., Adimora A.A., Smith J.S. Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies. AIDS. 2008; 22(12): 1493-501. https://dx.doi.org/10.1097/QAD.0b013e3283021a37
- Larsson L., Rymo L., Berglundh T. Sp1 binds to the G allele of the -1087 polymorphism in the IL-10 promoter and promotes IL-10 mRNA transcription and protein production. Genes Immun. 2010; 11(2): 181-7. https://dx.doi.org/10.1038/gene.2009.103
- Cauci S., Santolo M. di, Casabellata G., Ryckman K., Williams S.M., Guaschino S. Association of interleukin-1beta and interleukin-1 receptor antagonist polymorphisms with bacterial vaginosis in non-pregnant Italian women. Mol. Hum. Reprod. 2007; 13(4): 243-50. https://dx.doi.org/10.1093/molehr/gam002
- Ryckman K.K., Simhan H.N., Krohn M.A., Williams S.M. Predicting risk of bacterial vaginosis: the role of race, smoking and corticotropin-releasing hormone-related genes. Mol Hum Reprod. 2009; 15(2): 131-7. https://dx.doi.org/10.1093/molehr/gan081
- White S., Acierno R., Ruggiero K.J., Koenen K.C., Kilpatrick D.G., Galea S. et al. Association of CRHR1 variants and posttraumatic stress symptoms in hurricane exposed adults. J. Anxiety Disord. 2013; 27(7): 678-83. https://dx.doi.org/10.1016/j.janxdis.2013.08.003
Received 27.05.2025
Accepted 18.06.2025
About the Authors
Ada T. Uruymagova, PhD student at the Department of Obstetrics, Gynecology, Perinatology and Reproductology, V.I. Kulakov NMRC for OGP, Ministry of Health of Russia, 4 Ac. Oparina str., Moscow, 117997, Russia, +7(925)704-33-97, ada.uruimagova@yandex.ru, https://orcid.org/0000-0001-5650-3377Elena A. Mezhevitinova, Dr. Med. Sci., Leading Researcher at the Scientific and Outpatient Department, V.I. Kulakov NMRC for OGP, Ministry of Health of Russia,
4 Ac. Oparina str., Moscow, 117997, Russia, mejevitinova@mail.ru, https://orcid.org/0000-0003-2977-9065
Andrey E. Donnikov, PhD, Head of the Laboratory of Molecular Genetic Methods, V.I. Kulakov NMRC for OGP, Ministry of Health of Russia,
4 Ac. Oparina str., Moscow, 117997, Russia, https://orcid.org/0000-0003-3504-2406